Found: 10
Select item for more details and to access through your institution.
Correction to: Efgartigimod: First Approval.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Pharmacotherapeutic Treatment of Glioblastoma: Where Are We to Date?
- Published in:
- Drugs, 2022, v. 82, n. 5, p. 491, doi. 10.1007/s40265-022-01702-6
- By:
- Publication type:
- Article
Daridorexant: First Approval.
- Published in:
- Drugs, 2022, v. 82, n. 5, p. 601, doi. 10.1007/s40265-022-01699-y
- By:
- Publication type:
- Article
Aumolertinib: A Review in Non-Small Cell Lung Cancer.
- Published in:
- Drugs, 2022, v. 82, n. 5, p. 577, doi. 10.1007/s40265-022-01695-2
- By:
- Publication type:
- Article
Correction to: Abrocitinib: First Approval.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Sugemalimab: First Approval.
- Published in:
- Drugs, 2022, v. 82, n. 5, p. 593, doi. 10.1007/s40265-022-01693-4
- By:
- Publication type:
- Article
Nirmatrelvir Plus Ritonavir: First Approval.
- Published in:
- Drugs, 2022, v. 82, n. 5, p. 585, doi. 10.1007/s40265-022-01692-5
- By:
- Publication type:
- Article
Contemporary Management of Dyslipidemia.
- Published in:
- Drugs, 2022, v. 82, n. 5, p. 559, doi. 10.1007/s40265-022-01691-6
- By:
- Publication type:
- Article
Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
- Published in:
- Drugs, 2022, v. 82, n. 5, p. 533, doi. 10.1007/s40265-022-01688-1
- By:
- Publication type:
- Article
From a Symptom-Based to a Mechanism-Based Pharmacotherapeutic Treatment in Complex Regional Pain Syndrome.
- Published in:
- Drugs, 2022, v. 82, n. 5, p. 511, doi. 10.1007/s40265-022-01685-4
- By:
- Publication type:
- Article